Execs On The Move, June 2012
Executive Summary
Recent executive-level company changes and promotions in the biotech, pharmaceutical and medical device industries.
Company Changes
ARNOLD, Peter
To:Kinetic Concepts Inc., SVP, Innovation & Strategic Mktg. (May)
From:Newcastle Science City, CEO
Tel:210-255-6157
BARR, John
To:Bausch & Lomb Inc., Global Pres., Surgical (May)
From:AGA Medical Holdings Inc., Pres. & CEO
Tel:585-338-6000
BRUHN, Suzanne L., PhD
To:Promedior Inc., Pres. & CEO (May)
From:Shire Human Genetic Therapies Inc., SVP, Strategic Planning & Program Mgmt.
Tel:610-560-1435
CALAIS, Philippe, DPharm
To:Antisense Pharma GMBH, CEO (May)
From:Gestion Univalor, CEO
Tel:+49 941 92013 0
CAUWENBERGH, Geert
To:RXi Pharmaceuticals Corp., Pres. & CEO (May)
From:Barrier Therapeutics Inc., Chmn. & CEO
Tel:508-767-3861
COLLINS, Cynthia
To:GenVec Inc., Pres. & CEO (May)
From:Beckman Coulter Inc., Group VP, Cellular Analysis
Tel:240-632-0740
CONLEY, Pamela B., PhD
To:iPierian Inc., VP, Research (May)
From:Portola Pharmaceuticals Inc., VP, Research Biology
Tel:650-872-4700
COOMBS, Martyn
To:Jubilant DraxImage Inc., Pres. (May)
From:Asterand PLC, CEO
Tel:888-633-5343
DAVID, Eric Michael, MD
To:Organovo Holdings Inc., Chief Strategy Officer (May)
From:McKinsey & Co., Associate Partner
Tel:858-550-9994
DESROCHERS, David
To:TruTouch Technologies Inc., CFO (May)
From:Consultant
Tel:866-721-6221
DEVITA, Robert J., PhD
To:Agios Pharmaceuticals Inc., VP, Chemistry (May)
From:Merck Research Laboratories, Dir., Medicinal Chemistry
Tel:617-649-8600
DORSCH, Marion, PhD
To:Agios Pharmaceuticals Inc., VP, Biology (May)
From:Sanofi Oncology, Dir., Cancer Biology
Tel:617-649-8600
EDWARDS, Stephen
To:Zonare Medical Systems Inc., VP, US Sales (May)
From:GE Healthcare, National Sales Mgr., General Imaging Ultrasound
Tel:650-230-2800
FACHER, Evan
To:SironRX Therapeutics Inc., CEO (May)
From:MedRad Inc., General Mgr., Interventional Ops.
Tel:216-445-0830
GLIDDEN, Paul, PhD
To:NanoSmart Pharmaceuticals Inc., VP, R&D (May)
From:BioVascular Inc., VP, Dev.
Tel:949-305-2020
HAYDEN, Michael R., MD, PhD
To:Teva Pharmaceutical Industries Ltd., Pres., Global R&D & CSO (May)
From:University of British Columbia, Killam Professor of Medicinal Genetics
Tel:+972 3 9267267
HEALY, Mimi, PhD
To:LaserGen Inc., CEO (May)
From:Bacterial Barcodes, CEO
Tel:713-747-3380
HEDRICK, Eric, MD
To:Epizyme Inc., CMO (May)
From:Pharmacyclics Inc., VP, Oncology Dev.
Tel:617-229-587
HEIDEN, William K.
To:AMAG Pharmaceuticals Inc., Pres. & CEO (May)
From:GTC Biotherapeutics Inc., Pres. & CEO
Tel:617-498-3300
HOLLAND, Christopher S.
To:CR Bard Inc., SVP, CFO (May)
From:Aramark Corp., SVP, Fin. & Treas.
Tel:800-367-2273
HURD, Don
To:AspenBio Pharma Inc., SVP, Chief Commercial Officer (May)
From:Consultant
Tel:303-794-2000
JOOSTE, LeRoux
To:Antares Pharma Inc., SVP, Sales & Mktg. (May)
From:Cephalon Inc., VP, Commercial Assessment & New Product Planning
Tel:609-359-3020
JUSERIUS, Henric
To:Medivir AB, EVP, Commercial (May)
From:Actelion Pharmaceuticals Ltd., Commerical Dir., Nordic Region
Tel:+46 8 5468 3100
LARKIN, Tom
To:Acella Pharmaceuticals LLC, VP, Sales & Mktg. (May)
From:Major Pharmaceuticals, Pres.
Tel:678-325-5189
LENZ, Brian
To:ADMA Biologics Inc., VP, CFO (May)
From:CorMedix Inc., CFO & COO
Tel:201-478-5552
LOH, Evan, MD
To:Paratek Pharmaceuticals Inc., CMO (May)
From:Pfizer Pharmaceuticals, SVP, Worldwide R&D
Tel:617-275-0039
MARGOLIES, Matthew S.
To:Angeion Corp., EVP, Global Sales (May)
From:Cardinal Health Inc., SVP, Sales & Mktg. Nuclear Pharmacy
Tel:612-315-2000
MILBY, Randy
To:CorMedix Inc., COO (May)
From:WaterStone Bridge LLC, Founding Partner
Tel:908-517-9500
OLSON, Bill
To:Advanced Cardiac Therapeutics Inc., Pres. & CEO (May)
From:Satient Ventures, CEO
Tel:949-500-0192
PAKOLA, Steve, MD
To:Amakem NV, CMO (May)
From:ThromboGenics NV, CMO
Tel:+32 11 286 982
POMBO-VILLAR, Esteban, PhD
To:Oxford BioTherapeutics Ltd., COO (May)
From:Novartis Institue for Biomedical Research, Head, Alliance Mgmt.
Tel:+44 1235 861770
RATINI, Robert
To:InspireMD Inc., VP, Sales & Mktg. (June)
From:Orbusneich Medical Hoevelaken, Dir., Mktg.
Tel:+972 3691 7691
ROJKJAER, Lisa, MD
To:Molecular Partners AG, CMO (May)
From:Morphosys AG, VP, Head, Clinical Dev.
Tel:+41 44 755 7700
ROOS, Paul
To:Synthon BV, CFO (May)
From:Kempen & Co., Exec. Dir., Corp. Finance
Tel:+31 24 3727 700
RUBAN, Charles
To:DBV Technologies, Chief Dev. Officer (May)
From:Stallergenes SA, SVP, Product Dev.
Tel:+33 1 55 42 78 78
RUSSELL, Simon, PhD
To:Creabilis SA, CBO (May)
From:Novartis Pharma AG, Head, Global Mktg., Ilaris
Tel:+39 125 53543
SAINZ, Maria
To:CardioKinetix Inc., Pres. & CEO (May)
From:Stryker Neurovascular, General Mgr.
Tel:650-364-7016
SEELEY, Bruce J.
To:NanoString Technologies Inc., SVP, General Mgr., Diagnostics (May)
From:Seattle Genetics Inc., EVP, Commercial
Tel:206-378-6266
SHOTT, Ian
To:Albany Molecular Research Inc., Pres., AMRI Europe (May)
From:Shott Consulting Ltd., Managing Dir.
Tel:518-512-2000
SIMMONS, David
To:Pharmaceutical Product Development Inc., Chmn. & CEO (May)
From:Pfizer Inc., Pres. & General Mgr., Emerging Markets & Established Products
Tel:910-251-0081
SQUARER, Ron
To:Array BioPharma Inc., CEO (April)
From:Hospira Inc., Chief Commercial Officer
Tel:303-386-1390
TOMLINSON, Bruce
To:PDL BioPharma Inc., VP, CFO (June)
From:InterMune Inc., Chief Accounting Officer, VP, Fin. & Corp. Controller
Tel:775-832-8500
TUCKER, John
To:Incline Therapeutics Inc., SVP, Chief Commercial Officer (May)
From:AMAG Pharmaceuticals Inc., VP, Commercial Ops.
Tel:206-621-7200
WRIGHT, Jack
To:Althea Technologies Inc., VP, Sales & Mktg. (May)
From:Catalent Pharma Solutions Inc., VP, Bus. Dev., Oral Technologies
Tel:858-882-0123
Promotions
ANDRULONIS, Gregory S.
To:Covidien PLC
New Title:VP, Treasurer (May)
Previous Title:VP, Assistant Treasurer, Capital Planning & Markets
Tel:+353 1 438 1700
ASAR, Vinit K.
To:Hanger Orthopedic Group Inc.
New Title:CEO (May)
Previous Title:Pres. & COO
Tel:301-986-0701
BRANDICOURT, Olivier
To:Pfizer Inc.
New Title:Pres. & General Mgr., Emerging Markets & Established Products (June)
Previous Title:Pres. & General Mgr., Primary Care
Tel:212-733-2323
BRODY, Lee
To:SRS Medical Corp.
New Title:CEO (May)
Previous Title:COO
Tel:978-663-2800
CAMPBELL, Todd D.
To:ValveXchange Inc.
New Title:VP, Operations (May)
Previous Title:Senior Exec. Dir., Product Dev.
Tel:303-648-4077
CHUNG, Danny
To:Sinovac Biotech Ltd.
New Title:CFO (May)
Previous Title:Finance Dir.
Tel:+86 10 8289 0088
CLUBB, Kathryn
To:Ivivi Health Sciences LLC
New Title:CEO (May)
Previous Title:Pres. & COO
Tel:415-814-2460
GAO, David
To:China Biologic Products Inc.
New Title:Chmn. & CEO (May)
Previous Title:Chmn.
Tel:+86 10 6598 3099
GUTTMAN, Tim G.
To:AmerisourceBergen Corp.
New Title:SVP, CFO (May)
Previous Title:Acting CFO
Tel:610-727-7000
JOYCE, R. Todd
To:Watson Pharmaceuticals Inc.
New Title:CFO, Global (April)
Previous Title:EVP,CFO
Tel:862-261-7000
MOLNAR, Dennis
To:Paratek Pharmaceuticals Inc.
New Title:Pres. & CEO (May)
Previous Title:VP, Corp. Dev.
Tel:617-275-0039
WEBER, Stefan
To:Newron Pharmaceuticals SPA
New Title:CEO (May)
Previous Title:CFO
Tel:+39 02 610 3461
YOUNG, John
To:Pfizer Inc.
New Title:Pres. & General Mgr., Primary Care (June)
Previous Title:Regional Pres., Europe & Canada, Primary Care
Tel:212-733-2323
Resignations
HANSEN, Robert D.
From:Electromed Inc., Chmn. & CEO (May)
Tel:952-758-9299
KUO, Y. Tristan
From:China Biologic Products Inc., CFO (May)
Tel:+86 10 6598 3099